Yusuf Yılmaz

机构：Recep Tayyip Erdoğan University, Center for Outcomes Research in Liver Diseases, Global Health Council, Teknoloji Arastirma ve Gelistirme Endustriyel Urunler Bilisim Teknolojileri San Tic, Marmara University · ORCID：0000-0003-4518-5283

发表论文 412 篇 · 总被引 30823 次 · h-index 60

代表论文

• Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD (2025 · Journal of Hepatology · 被引 43)
• Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study (2025 · Hepatology · 被引 12)
• Two‐Decade Trends in MASLD and Its Complications in the Middle East and North Africa (2010–2021) (2025 · Liver International · 被引 12)
• Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study (2025 · Hepatology · 被引 10)
• Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis (2025 · Frontiers in Pharmacology · 被引 4)
• Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement (2026 · Gut · 被引 3)